SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-266358
Filing Date
2022-10-21
Accepted
2022-10-21 07:46:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d305402ddefa14a.htm DEFA14A 42111
  Complete submission text file 0001193125-22-266358.txt   43091
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39756 | Film No.: 221322200
SIC: 2834 Pharmaceutical Preparations